Latest Regulatory Progress News

Prodigy Gold NL has unveiled its comprehensive exploration plans for 2025, targeting resource expansion at Hyperion and Tregony deposits while advancing development options at Old Pirate. The company aims to leverage drilling results and metallurgical studies to accelerate project development in the Northern Territory.

The a2 Milk Company delivered solid first-half FY25 results with revenue up 10.1% and net profit rising 7.6%, driven by strong growth in China and the USA despite supply constraints and ANZ challenges. The company also declared its first-ever interim dividend and upgraded its full-year outlook.

AVITA Medical's Q4 2024 earnings reveal strong commercial growth alongside the launch of Cohealyx, a novel collagen-based skin substitute that promises to transform acute wound care.

VHM Limited has unveiled a staged development plan for its Goschen Rare Earths and Mineral Sands Project, targeting first production by late 2026 and a scalable expansion to 5Mtpa by 2029 with robust financial returns.

KALINA Power has significantly expanded its land holdings in Alberta, boosting its potential Power-CCS capacity to 1.7 GW to meet surging demand for data centre power solutions with carbon capture.

DigitalX Limited has significantly increased its Solana holdings and reported robust fund performance for January 2025, capitalizing on favorable market and regulatory shifts.

Pure Hydrogen has handed over Australia’s first hydrogen fuel cell rear loader garbage truck to Solo Resource Recovery, marking a milestone in sustainable waste management and clean energy adoption.

Neurizon Therapeutics has been granted a pivotal US patent for its lead drug candidate NUZ-001, extending protection until 2039 and enhancing its commercial and clinical positioning in neurodegenerative disease treatment.

Bio-Gene Technology Limited has secured A$3 million in U.S. Department of Defense grants to accelerate development of its two nature-derived insecticides, Flavocide and Qcide, targeting both military and civilian markets.

New Murchison Gold Limited (ASX:NMG) reveals a robust Feasibility Study for its Crown Prince Gold Deposit, projecting $226 million pre-tax cash flow over 30 months with a low $5.4 million capital outlay. Mining is slated to start mid-2025, positioning NMG on the cusp of production.

Vanadium Resources Limited (VR8) reports ongoing strategic equity and offtake discussions with tier-1 partners for its Steelpoortdrift Vanadium Project, alongside cost reduction measures and progress on environmental approvals.

Argent BioPharma reports strategic cost-cutting moves including facility closures and delisting from the LSE, while securing German distribution approval and raising significant capital to support its drug pipeline.